Nanoparticle Formulations of Poly (ADP-ribose) Polymerase Inhibitors for Cancer Therapy.

Singh, Bijay; Yang, Shicheng; Krishna, Apurva; Sridhar, Srinivas

Singh, Bijay; Yang, Shicheng; Krishna, Apurva; Sridhar, Srinivas.

Afiliación

Singh B; Nanomedicine Innovation Center, Northeastern University, Boston, MA, United States.
Yang S; Department of Physics, Northeastern University, Boston, MA, United States.
Krishna A; Nanomedicine Innovation Center, Northeastern University, Boston, MA, United States.
Sridhar S; Department of Chemical Engineering, Northeastern University, Boston, MA, United States.

Front Chem ; 8: 594619, 2020.

Article en En | MEDLINE | ID: mdl-33330383

Palabras clave

Cancer therapy; PARP inhibitor; nanomedicine; nanoparticle; poly(ADP-ribose) polymerase (PARP)

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Idioma: En Revista: Front Chem Año: 2020 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google